RIGL

RIGL

USD

Rigel Pharmaceuticals Inc. Common Stock

$28.380-1.710 (-5.683%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$30.090

Máximo

$30.795

Mínimo

$28.080

Volume

0.31M

Fundamentos da empresa

Capitalização de mercado

509.1M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.71M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $13.91Atual $28.380Máximo $43.72

Notícias relacionadas

PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...

Ver mais
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
CNBC

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

Ver mais
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'
PR Newswire

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on...

Ver mais
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update